← board
NTRR
distress 8/10 · high distress / dilution risk$0.000%today-67% from 52w high
Revenue
pre-revenue
Liquidity
$0M
Runway
0.0 yrs
Shares 1y
+24216%
Price & events
+0.0% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.0%
1D
+0.0%
1W
-50.0%
1M
-33.3%
3M
+0.0%
6M
-66.7%
1Y
-60.0%
2Y
-96.7%
5Y
-94.6%
All
Overview
- Market Cap
- $291.79K
- Volume
- 1.00M
- 52 Week Range
- $0.00 – $0.00
- Total Shares
- 2.92B
- Float Shares
- 2.90B
- % Held by Insiders
- 0.69%
- % Held by Institutions
- 0.00%
- RVOL
- 0.81x
- Beta
- 46.75
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
Shares out: 2,917,899,124 · 0 offerings/1y · 0 PIPEs
- none
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.